Drug Controller General of India
-
Bharat Biotech submits phase 3 trial data of Covaxin, expert panel to meet today to discuss results
Scroll Staff
-
Coronavirus vaccine: ‘We will probably have something in hand in new year,’ says top official
Scroll Staff
-
Coronavirus: Drug controller tells Serum Institute to stop recruiting for further vaccine trials
Scroll Staff
-
Coronavirus: Glenmark defends pricing of its favipiravir drug, calls it ‘effective treatment option’
Scroll Staff
-
Drug controller clears psoriasis injection for restricted emergency use on Covid-19 patients
Scroll Staff
-
Slow and opaque decisions during Covid-19 crisis put the spotlight on India’s drug regulator
Arunabh Saikia
-
Coronavirus: Pharma firm Hetero gets drug controller’s nod to produce, market remdesivir
Scroll Staff
-
E-pharmacies: Doctors fear rise in self-medication and abuse unless online drug sales are checked
Priyanka Vora